What this study is
The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.
What's being tested
- Observation
Intervention · OTHER
Understanding the biology of skull base tumors will teach the investigators about the genesis and/or mechanisms of treatment resistance. The investigators hope to ultimately identify new targets which will add to the armamentarium by which to treat these tumors.
Study details
- Sponsor
- University of Pittsburgh
- Conditions
- Skull Base Neoplasm · Cellular Pathology
- Enrolling
- 4,000 people
- Starts
- 2018-10-03
- Est. completion
- 2028-10-03
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Diagnosis of a skull base tumor
You can't join if
- Insufficient tumor sample at time of resection
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Benita Valappil, MPH · Contact412-864-1744valappilb2@upmc.edu
Recruiting
Study team
Sponsor
University of Pittsburgh
Study ID STUDY19070185
Principal investigator
Paul Gardner, MD
Associate Professor
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.